- https://doi.org/10.48317/imist.prsm/morjchem-v9i2.21931
DFT and Molecular docking study of natural molecules proposed for COVID-19 treatment
Translate Article 
Take Notes Abstract Emergence and spread of corona virus disease 2019 (COVID-19), caused by severe respiratory syndrome coronavirus, is considered a public health emergency threatening global health systems, as of June, 2020, It caused a cumulative total of 9,033,423 confirmed cases and more than 469,539 deaths across 215 countries, person to-person transmission has being identified as the route for spreading. So far, the lack of effective vaccines for the treatment or prevention of Covid-19 has further worsened the situation. In this context, the present study aims to assess whether naturally occurring components have an antiviral effect via a computational modeling approach. Density Functional theory (DFT) was performed to estimate the kinetic parameters, frontier molecular orbitals, molecular electrostatic potential as well as chemical reactivity descriptors of various ligands. The results revealed that Crocin and Digitoxigenin exhibited a potential applicant with the lowest resistance to electronic charge transfer with a chemical hardness of 2.19eV and 2.96eV respectively, as well as the lowest HOMO-LUMO difference. In addition to the DFT calculation, a docking simulation study was conducted on the SARS-CoV-2 base protease (PDB: 6LU7) to determine the binding affinity of ligands. The findings show that Crocin exhibits the lowest binding energy of -8.1 Kcal/mol and may be a good inhibitor of CoV-2-SARS compared to hydroxychloroquine and chloroquine, which have a binding affinity of -5.4 and -4.9 Kcal/mol, respectively. The high binding affinity of L3 was assigned to the existence of 14 hydrogen bonds connecting the ligand to the critical amino acid residues of the receptor.
- Research Article
1 - 10.1016/j.anai.2020.08.023
- Aug 25, 2020
- Annals of Allergy, Asthma & Immunology
US public health resources for coronavirus disease 2019 that are relevant to allergy-immunology
- Front Matter
- 141
- 10.1016/j.jaci.2020.04.035
- May 7, 2020
- Journal of Allergy and Clinical Immunology
Air pollution, racial disparities, and COVID-19 mortality
- Research Article
- 42
- 10.1016/j.amepre.2020.05.004
- May 30, 2020
- American Journal of Preventive Medicine
Preventing COVID-19 and Its Sequela: “There Is No Magic Bullet... It's Just Behaviors”
- Research Article
- 22
- 10.1016/j.jtcvs.2020.04.059
- Apr 27, 2020
- The Journal of Thoracic and Cardiovascular Surgery
Adult cardiac surgery and the COVID-19 pandemic: Aggressive infection mitigation strategies are necessary in the operating room and surgical recovery
- Research Article
- 2
- 10.30492/ijcce.2020.127740.4132
- Sep 22, 2020
- Iranian Journal of Chemistry & Chemical Engineering-international English Edition
Two drugs have been authorized by the Algerian health Ministry to be used in Algeria to treat coronavirus disease 2019 (COVID-19) patients, once is Hydroxychloroquine (HCQ) and the other is Chloroquine (CQ). These drugs have been theoretically studied in order to know their active sites, vibrational and electronic properties using Density Functional Theory (DFT) at the B3LYP/6-31G (d.p) level. The optimized molecular structures, the vibrational spectra, the HOMO and LUMO properties, dipole moments, Molecular Electrostatic Potentials (MEP) and atomic charges are calculated. In addition, the reactivity of drug molecules has been discussed calculating some descriptors such as energy gap, hardness, local softness, electronegativity and electrophilicity.
- Research Article
- 230
- 10.1111/ajt.15967
- May 27, 2020
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
COVID-19 in kidney transplant recipients.
- Discussion
- 10.1016/j.clcc.2020.07.002
- Jul 9, 2020
- Clinical Colorectal Cancer
The Asian Approach to the Management of Gastrintestinal Cancer Patients During the COVID-19 Pandemic Era
- Front Matter
- 8
- 10.1002/phar.2394
- May 1, 2020
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Peer Reviewed
- Front Matter
- 9
- 10.1016/j.ijrobp.2020.06.055
- Sep 2, 2020
- International journal of radiation oncology, biology, physics
Injuries From Asymptomatic COVID-19 Disease: New Hidden Toxicity Risk Factors in Thoracic Radiation Therapy
- Discussion
- 11
- 10.1053/j.jvca.2020.07.070
- Jul 30, 2020
- Journal of Cardiothoracic and Vascular Anesthesia
Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice?
- Front Matter
- 367
- 10.7326/m20-1133
- Mar 27, 2020
- Annals of Internal Medicine
As the COVID-19 pandemic accelerates in the United States, this commentary asks how oncology specialists and allied providers are balancing a delay in cancer diagnosis or treatment against the risk...
- Research Article
- 186
- 10.7326/m20-1334
- Mar 31, 2020
- Annals of Internal Medicine
Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for COVID-19. The auth...
- Research Article
- 412
- 10.1016/j.jhepr.2020.100113
- Apr 2, 2020
- JHEP Reports
Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper.
- Research Article
- 10.47144/phj.v53i1.1907
- Apr 27, 2020
- Pakistan Heart Journal
MANAGEMENT OF COVID-19 IN PERSPECTIVE OF CARDIOLOGISTS
- Discussion
- 55
- 10.1016/j.injury.2020.04.012
- Apr 15, 2020
- Injury
CoViD-19 and ortho and trauma surgery: The Italian experience
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.
